FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis (vol 28, pg 285, 2015)

被引：44
|
作者：
Dahan, Rony
Sega, Emanuela
Engelhardt, John
Selby, Mark
Korman, Alan J.
Ravetch, Jeffrey V.
机构：
来源：
CANCER CELL | 2015年 / 28卷 / 04期
关键词：
D O I：
10.1016/j.ccell.2015.09.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [31] Hematologic Cancers Break Down a 'Checkpoint': Targeting the PD-1/PD-L1 Axis
    Timmerman, John
    ONCOLOGY-NEW YORK, 2015, 29 (06): : 440 - 441
  • [32] A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity
    Luan, Yan
    Chai, Dafei
    Peng, Jianjian
    Ma, Shuli
    Wang, Min
    Ma, Hui
    Li, Xiang
    Fu, Shilong
    Pan, Xiaolong
    Wang, Xiaoxiao
    Qin, Songbing
    Xu, Ting
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 31 : 248 - 256
  • [33] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [34] Targeting the host immune system: PD-1 and PD-L1 antibodies and breast cancer
    Dawood, Shaheenah
    Rugo, Hope S.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2016, 10 (04) : 336 - 342
  • [35] Blocking the PD-1/PD-L1 axis for cancer therapy
    Drake, C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S12 - S13
  • [36] Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis
    Krutzek, Fabian
    Kopka, Klaus
    Stadlbauer, Sven
    PHARMACEUTICALS, 2022, 15 (06)
  • [37] Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1
    Patera, Andriani C.
    Drewry, Anne M.
    Chang, Katherine
    Beiter, Evan R.
    Osborne, Dale
    Hotchkiss, Richard S.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 100 (06) : 1239 - 1254
  • [38] Role for the PD-1/PD-L1 axis in the development of COPD
    Ritzmann, F.
    Vella, G.
    Angenendt, A.
    Lis, A.
    Herr, C.
    Bals, R.
    Beisswenger, C.
    PNEUMOLOGIE, 2020, 74 : S73 - S73
  • [39] Targeting the PD-1/PD-L1 interaction in nasopharyngeal carcinoma
    Johnson, David
    Ma, Brigette B. Y.
    ORAL ONCOLOGY, 2021, 113
  • [40] Molecular interactions of antibodies with PD-1/PD-L1 proteins
    Vasilakaki, Sofia
    Vathiotis, Ioannis
    Panagiotou, Emmanouil
    Dimakakos, Evangelos
    Gomatou, Georgia
    Kotteas, Elias
    IMMUNOTHERAPY, 2024, 16 (01) : 21 - 28
12345